Twin Lakes Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-139,397
| Closed | -$3.3M | – | 250 |
|
|
2022
Q1 | $3.3M | Buy |
139,397
+817
| +0.6% | +$19.3K | 1.86% | 18 |
|
|
2021
Q4 | $4.74M | Sell |
138,580
-707
| -0.5% | -$24.2K | 2.53% | 9 |
|
|
2021
Q3 | $2.47M | Sell |
139,287
-4,153
| -3% | -$73.6K | 1.45% | 25 |
|
|
2021
Q2 | $6.44M | Buy |
143,440
+556
| +0.4% | +$25K | 3.58% | 6 |
|
|
2021
Q1 | $3.7M | Buy |
142,884
+401
| +0.3% | +$10.4K | 2.28% | 13 |
|
|
2020
Q4 | $2.87M | Buy |
+142,483
| New | +$2.87M | 2.05% | 17 |
|